MarketCap
Vanda Pharmaceuticals VNDA
€ 3.60
0.24%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2006 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBALSPB |
Anteile |
58.9 M |
Marktkapitalisierung |
$ 238 M |
EBITDA (LTM) |
$ -150 M |
P/E (LTM) |
-1.451872 |
P/S (LTM) |
1.480719 |
EPS (LTM) |
-3.74 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Abeona Therapeutics
ABEO
|
$ 4.43 | 6.65 % | $ 235 M | Nasdaq Capital Market | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 19.12 | 2.39 % | $ 3.22 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 2.37 | 0.83 % | $ 13 M | NYSE American | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market |  Israel |
 |
IGM Biosciences
IGMS
|
- | - | $ 76.9 M | Nasdaq Global Select Market,SPB | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market |  Canada |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Neurocrine Biosciences
NBIX
|
$ 135.71 | 0.68 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 231.83 | 0.11 % | $ 30.4 B | Nasdaq Global Select Market,SPB | USA |
 |
NuCana plc
NCNA
|
$ 0.99 | 0.98 % | $ 11.1 B | Nasdaq Global Select Market |  Britain |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
Burford Capital Limited
BUR
|
$ 3.0 | 0.15 % | $ 657 M | NYSE | Britain |
 |
Aprea Therapeutics
APRE
|
$ 0.58 | 2.27 % | $ 3.79 M | Nasdaq Global Select Market,SPB | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |
 |
AnaptysBio
ANAB
|
$ 46.61 | 4.37 % | $ 1.35 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 19.98 | 2.17 % | $ 286 M | Nasdaq Global Select Market,SPB | USA |
 |
Minerva Neurosciences
NERV
|
$ 2.35 | 2.98 % | $ 19.9 M | Nasdaq Global Market | USA |
 |
Merrimack Pharmaceuticals
MACK
|
- | - | $ 216 M | Nasdaq Global Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 10.34 | 1.35 % | $ 283 M | Nasdaq Global Market,SPB | Israel |
 |
argenx SE
ARGX
|
$ 819.14 | 3.42 % | $ 50.2 B | Nasdaq Global Select Market |  Niderland |
 |
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 59.75 | 0.12 % | $ 122 B | NYSE,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.8 | 1.35 % | $ 133 M | Nasdaq Global Select Market | USA |
 |
Cabaletta Bio
CABA
|
$ 1.41 | 0.5 % | $ 142 M | Nasdaq Global Select Market | USA |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | Canada |
 |
CytomX Therapeutics
CTMX
|
$ 2.28 | 8.07 % | $ 314 M | Nasdaq Global Select Market | USA |
 |
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Novavax
NVAX
|
$ 11.26 | 1.42 % | $ 1.82 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 38.83 | 0.14 % | $ 173 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 150.62 | 0.16 % | $ 292 B | NYSE |  Schweiz |
 |
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 9.18 | 2.64 % | $ 115 M | Nasdaq Global Select Market,SPB | USA |
 |
Ocular Therapeutix
OCUL
|
$ 6.87 | 2.5 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 6.58 | 1.03 % | $ 572 M | Nasdaq Global Select Market | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.51 | 0.72 % | $ 2.22 B | Nasdaq Global Market | Canada |
 |
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.32 | 0.11 % | $ 352 M | Nasdaq Global Select Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market | Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | USA |
 |
Axsome Therapeutics
AXSM
|
$ 157.14 | 0.08 % | $ 7.82 B | Nasdaq Global Market,SPB | USA |
|
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | USA |
 |
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.07 | 0.97 % | $ 169 M | Nasdaq Global Select Market | Israel |
 |
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | USA |